While CYCLONE 2's negative findings on abemaciclib plus abiraterone will be discussed, attention will also be on emerging treatments such as ARV-766, a PROTAC androgen receptor degrader, and tarlatamab, targeting DLL3 for neuroendocrine prostate cancer. 0 Medscape © 2024 WebMD, LLC Any ...
has seen remarkable progress. This article, tailored for students from elementary to high school, aims to educate you on the basics of prostate cancer, new therapies, and how these innovations can lead to a cure. Let's dive into the world of medical science...
New Promising Treatments for Advanced Prostate Cancer2020;382:2187-2196). The primary endpoint was sustained testosterone suppression to castrate levels (< 50 ng/dL) through 48 weeks in the treated population.doi:10.1097/01.COT.0000695672.84740.75Kumar Das, Dibash...
With prostate cancer, when looking at where the long-term treatments are going, it is probably going to evolve more into how we are dealing with more advanced stages of prostate cancer. Like most cancers in general, [we will be] looking at what potential immunotherapies in the future would ...
The prostate cancer condition center is a comprehensive resource for cancer news & oncologist insights on prostate cancer. Read more about cancer at CURE.
If you have high PSA levels but biopsies don’t find cancer, a urine test known as a PCA-3 looks for cancer. This can prevent the need for repeat biopsies in some men. What Are the Treatments for Prostate Cancer? If you need treatment, your doctor will decide the type. Decisions about...
There is an unmet need to develop new treatments for metastatic prostate cancer. With the development of targeted radioligand therapies, bispecific T cell engagers, antibody–drug conjugates and chimeric antigen receptor T cell (CAR T) therapies, tumor-associated cell surface antigens have emerged as...
Other prostate cancer symptoms can include: Loss of libido (sex drive).Side effects of drug treatments for prostate cancer can cause a loss of interest in sex and erection problems. A common treatment for prostate cancer is hormone therapy, which is used to slow your body down from making te...
Article Open access 30 August 2024 Introduction With multi-parametric magnetic resonance imaging (mpMRI), targeted fusion biopsy has been shown to better detect clinically-significant prostate cancer (csPCa) compared to transrectal biopsy [1]. However, systematic biopsy cannot be omitted as 5–16% ...
cancer," discussed at New York Roentgen Conference, 2005. ."unproven screening test, the PSA blood test for prostate cancer." Journal of American College of Radiology, 2005 "New non invasive treatments reduce impotence and incontinence" Prostate Cancer Research Institute, 2005 "image guidance with ...